0001114220-18-000055.txt : 20180516 0001114220-18-000055.hdr.sgml : 20180516 20180516164027 ACCESSION NUMBER: 0001114220-18-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180515 FILED AS OF DATE: 20180516 DATE AS OF CHANGE: 20180516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neylan John F. CENTRAL INDEX KEY: 0001640447 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 18840449 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-466-3500 MAIL ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 4 1 wf-form4_152650321264174.xml FORM 4 X0306 4 2018-05-15 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001640447 Neylan John F. C/O KERYX BIOPHARMACEUTICALS, INC. ONE MARINA PARK DRIVE, 12TH FLOOR BOSTON MA 02210 0 1 0 0 Chief Medical Officer Common Stock 2018-05-15 4 S 0 1158 5.69 D 153156 D Sale of a total of 1,158 shares of common stock was made in order to satisfy Mr. Neylan's income tax withholding obligation upon the vesting of 4,063 shares of restricted stock on May 14, 2018. Mr. Neylan had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock. Includes 83,123 shares of restricted stock. /s/ Scott A. Holmes, Attorney-in-Fact 2018-05-16